Two cannabis treatments approved by UK’s NHS, Drake partners up with Canadian producer Canopy Growth to launch a new brand

Posted by
cannabis news

Medical cannabis

🇬🇧Two cannabis-based treatments for epilepsy and multiple sclerosis have been approved by National Health Service of United Kingdom. 

🇬🇧A poll has shown that at least 1,4 million people in the UK use «street cannabis» to cope with their chronic medically-diagnosed health conditions.

🇨🇦Recent cannabis study shows potential for treating post traumatic stress disorder (PTSD).


🇨🇦Adding to the wave of celebrities stepping into cannabis business, renowned hip-hop artist Drake partnered with Canadian cannabis giant Canopy Growth to launch the More Life Growth Company – new cannabis producer in Toronto. 

🇺🇸Former Canopy Growth CEO Bruce Linton joined US cannabis company Vireo Health as executive chairman. The shares of the company jumped 26% up after the announcement. 

Subscribe to Valuation420 newsletter to receive the selection of news, articles, analytics and expert interviews in your inbox weekly. 

Share us

Leave a Reply

Your email address will not be published. Required fields are marked *